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The differentiation of neutrophils in normal, abnormal, and leukemic disease 
states  has  been  extensively  characterized  from  the  aspects  of morphology, 
cytochemistry, and functional properties. However, in comparison to the many 
studies of membrane components as indices of differentiation in the lymphoid 
system, little attention has been given to analysis of the membrane structural 
changes that occur during granulocyte differentiation. Since the acquisition of 
receptors  and other  mature  cell  membrane  components is  closely  associated 
with functional differentiation, it is likely that identification of the structures 
and receptors  associated  with membrane  differentiation would provide  addi- 
tional perspectives of particular utility in studies of granulocyte physiology, as 
well as assistance in classification of certain abnormal disease states. 
Mature neutrophils have complement  (C) ~ receptors that are believed to be 
exclusively  CR1  (immune  adherence,  C4b-C3b  receptors)  but  not  CI~  (C3d 
receptors)  (1-4).  However,  there  have  been  no  studies  of the  specificity  of 
neutrophil C receptors for different fragments of C3 or C4 molecules, or of when 
C receptors  appear during neutrophil maturation.  By contrast, the specificity 
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Abbreviations  used in this paper: AML, acute myelogenous leukemia: B lymphocyte or B cell, 
bone marrow-derived lymphocyte; T  lymphocyte or T  cell, thymus-derived lymphocyte; BSA, 
bovine serum albumin; band or band form, neutrophil maturation stage proceeding the polymor- 
phonuclear stage; C, complement; CR1, complement receptor type one, the immune adherence 
(C4b-C3b) receptor; CI~, complement receptor type two, C3d receptor; C4b,  the 204,000 dalton 
fragment  of C4  generated by cleavage of C4 by Ci;  C3b,  the  181,000-dalton  fragment of C3 
generated by cleavage of C3 by C4-~  or trypsin; C3c (140,000 daltens) and C3d  (30,000 daltons) 
fragments are the fragments of C3b  generated by cleavage with C3b  inactivator, trypsin, or 
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complement complexes; Fc receptor, receptor for the Fc portion of IgG; HBSS, Hanks' balanced 
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BSA, PBS containing 1% BSA and 0.2% NAN,; SDS, sodium dodecyl sulfate. 
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and activity ofIgG Fc receptors have been studied in greater detail, and parallel 
studies  of  murine  neutrophil  maturation  have  now  demonstrated  that  Fc 
receptors appear at an early phase of neutrophil differentiation that precedes 
the appearance of C receptors  (5). 
In  a  companion  study,  immature  normal  human  granulocyte  precursors, 
including cells responsible for granulocyte-monocyte colony-forming cells, were 
recently  demonstrated  to  express  Ia  determinants  in  a  membrane  surface 
29,000-37,000 dalton bimolecular complex identical to that found on B lympho- 
cytes (6). In the present investigation, the specificity and characteristics of the 
different types of neutrophil C receptors are examined. Emphasis is placed on 
determining the interrelationships of C-receptor appearance with the expression 
of Ia antigens during the process of normal and leukemic granulocyte matura- 
tion. 
Materials and Methods 
Human  Subjects.  Blood  was  obtained  from  normal  healthy  volunteers  and  patients  with 
myeloid  leukemia.  Bone  marrow  was  obtained  from  ribs  removed  during  thoracotomy  from 
nonleukemic individuals. Patients with myeloid leukemia were classified by standard morpholog- 
ical  and  cytochemical criteria.  All patients  with  chronic  myelogenous  leukemia  (CML)  were 
shown to have the Philadelphia chromosome. 
Separation of Cells by Discontinuous Density Gradient Centrifugation.  Heparinized blood was 
mixed with an equal volume of 3% dextran T-500 (Pharmacia Fine Chemicals, Div. of Pharmacia 
Inc., Piscataway,  N. J.) in phosphate-buffered saline  (PBS) and after sedimentation of erythro- 
cytes for 30 min at room temperature,  the leukocyte-rich supernate was diluted with an equal 
volume of PBS. Marrow was flushed from 2.5-cm rib segments with Ca  ++ and Mg+÷-free Hanks' 
balanced salt solution (HBSS) containing 3.8% sodium citrate, 3.5% bovine serum albumin (BSA) 
and 20 U/ml deoxyribonuclease  (Sigma Chemical Co., St.  Louis, Mo.).  A  stock solution of 20% 
Hypaque-M (Winthrop Laboratories, New York) and 15% Ficoll 400 (Pharmacia Fine Chemicals) 
in water (d =  1.15-1.16 g/ml, 2O°C) was prepared and diluted with water to make various densities 
for cell separation.  Leukocyte suspensions  were distributed  into four groups  of 24  ×  105-mm 
siliconized glass centrifuge tubes,  6 ml per tube.  The first group of tubes was underlayered  in 
succession with 6-ml layers of 1.05,  1.06,  and 1.07 g/ml Ficoll-Hypaque. The Ficoll-Hypaque was 
pumped  beneath  the cell suspension  with a  syringe pump  (model 351,  Sage Instruments  Div., 
Orion Research Inc., Cambridge, Mass.) connected to capillary tubing that extended to the bottom 
of each tube. The second group of tubes received 1.07-,  1.08-,  and 1.09-g/ml layers, and the third 
group 1.09,  1.105 and 1.12 g/ml Ficoll-Hypaque. The fourth group of tubes received a single layer 
of 1.12  g/ml Ficoll-Hypaque. After centrifugation at  1,200 g  for 45 rain at 20°C,  the cell layers 
concentrated at each density interface were aspirated  with a  siliconized Pasteur pipet. The top 
layers of tube groups two and three were heterogeneous  with respect to cell density and  were 
discarded.  The 1.12-g/ml layer from the fourth group of tubes contained >98% of the nucleated 
cells and few, if any, erythrocytes.  This cell layer was used as the source of unseparated  cells. 
After one wash of each density layer with PBS containing 1% BSA and 0.2%  NaN3 (PBS/BSA), 
cell counts were made  to determine yield,  and  cytocentrifuge preparations  were  stained  with 
Wright-Giemsa to determine differential morphology. 
C-Receptor Assay.  EAC  (sheep  erythrocytes,  senstitized  with  rabbit  IgM  antibody  and 
complement) were prepared as previously described with the purified components of human C (7). 
The EAC14b used to form CRi-dependent rosettes were prepared with 50 pg of purified C4 (8) per 
109 EAC1, and produced nearly equivalent immune adherence as did the EAC1-3b. The EAC1-3d 
had  <2%  immune  adherence  activity compared  to  EAC1-3b,  and  were  frequently  completely 
negative in immune adherence. The potency of the EAC1-3d for detection of CR2 was assessed by 
rosette formation with cells from a  lymphoblastoid cell line that contained only CI~ and lacked 
CR1 (Daudi). 
C-receptor-dependent rosettes were formed in 10 × 75-mm plastic tubes by mixing together 0.1 
ml of EAC at  2  ×  108/ml  with  0.1  ml  of C-receptor-bearing cells at  4  ×  106/ml  in  PBS/BSA, 732  SURFACE  MARKERS  OF  NEUTROPHIL  MATURATION 
followed by incubation on a  tube rotator for 15 min at 37°C  (7).  Rosettes in the cell suspension 
were enumerated by phase-contrast microscopy, or alternatively, differential counts of rosetted 
cells were made from Wright-Giemsa-stained smears. For staining, rosette mixtures were pelleted 
at  100 g  for 2  rain,  resuspended in 20  ~1 of fetal calf serum,  and immediately smeared across 
microscopy slides with a  cover slip.  The smears were quickly dried with a  hair drier and then 
stained with Wright-Giemsa. By this technique, an even distribution of cells with good morphol- 
ogy was obtained, and rosettes of cells representing different stages of myeloid cell maturation 
could be easily distinguished (5). 
Detection ofHurnan la Antigens.  Human Ia antigens were detected by direct immunofluores- 
cence  with  a  rabbit  F(ab')2  antibody  conjugated  to  tetramethylrhodamine  isothiocyanate  as 
previously described (6,  9). 
Preparation  of C Fragments.  Highly  purified  C4  and  C3  were  prepared  by  the  recently 
published techniques of Bolotin et al. (8) and Tack and Prahl (10).  C4b was separated from native 
C4 on DEAE-Bio-Gel A  (Bio-Rad Laboratories, Richmond, Calif.) during the final step of the C4 
purification procedure (8). In agreement with the findings of Cooper (11) and Bolotin et al. (8), the 
a-chain of reduced C4b was shown by electrophoresis in sodium dodecyl sulfate (SDS)-polyacryl- 
amide gels to be 6,000 daltons less molecular weight than the a-chain of native C4, whereas the 
/3- and y-chains of C4b had molecular weights identical to those of native C4. C3b was prepared 
according to Bokisch et al.  (12)  by cleavage of C3 with 1% trypsin for 2 rain at 20°C.  C3b was 
separated from C3a by gel filtration on Sephacryl S-200  (Pharmacia Fine Chemicals) in 0.05 M 
sodium acetate, pH 5.6, containing 1.0 M sodium chloride (B. F., Tack, personal communication). 
This latter step did not cause the denaturation and precipitation of C3b that characterized the 
original separation technique (12) using 0.15 M NaC1 at pH 4.0. C3b was shown to be free of C3a, 
C3c,  and  C3d  by  electrophoresis  in  SDS-polyacrylamide  gels.  Ouchterlony  double-diffusion 
analysis with a  rabbit anti-C3d serum gave a  line of identity between C3b and C3d,  indicating 
that C3d determinants were exposed in the C3d region of fluid-phase C3b.  This activity of the 
anti-C3d against C3b was uneffected by absorption of the antiserum with C3c immobilized with 
cyanogen bromide on  Bio-Gel A-Sin  (Bio-Rad Laboratories).  Furthermore,  the anti-C3d had a 
similar  activity  with  immune  complex-bound  C3b  and  C3d  as  it  did  with  the  fluid-phase 
fragments.  Anti-C3d agglutinated both EAC1-3d and EAC1-3b to  a  titer of 1:2,400.  Thus,  this 
antiserum  demonstrated  that  the  C3d  region  was  exposed  in  both  fluid-phase  and  immune 
complex-bound C3b.  C3c was a  generous gift from Dr.  Brian Tack of the National Institutes of 
Health, Bethesda, Md.,  and was produced by cleavage of C3 with 1% porcine elastase for 4 h  at 
37°C,  followed  by  separation  from  C3d  on  Sephadex  G-100  in  0.05  M  sodium  acetate  pH  5.6 
containing 1.0 M NaC1.  The C3c produced by this method was free of detectable C3b and C3d by 
immunodiffusion and SDS-pelyacrylamide gel electrophoresis analysis. In immunodiffusion tests, 
elastase-generated C3c formed a  line of identity with trypsin-generated C3c and anti-C3, but did 
not form a  precipitin line with anti-C3d produced by immunization with trypsin-generated C3d. 
Although the molecular weights of the unreduced C3c fragments were similar, elastase-generated 
C3c differed from trypsin-generated C3c with respect to the specific cleavage sites in the C3b a'- 
chain.  Most  importantly,  few  other peptides  in the  a'-chain were  cleaved  with  elastase,  and 
unlike trypsin, elastase did not cleave the/]-chain. C3d was produced by cleavage of C3 with 2% 
trypsin at 37°C for 1 h, followed by separation from C3c and C3b by filtration on Sephadex G-200 
in  Veronal-buffered  saline  (12).  No  C3a,  C3b,  or  C3c  were  detected  in  the  C3d  by  SDS- 
polyacrylamide gel electrophoresis or by immunodiffusion. 
Assay for C-Receptor Specificity.  The C receptors of neutrophils were analyzed for specificity 
by tests for competitive inhibition of EAC rosette formation with fluid-phase fragments of C4 and 
C3.  4  x.  10  ~ neutrophils were resuspended  in  0.1  ml  of C-fragment dilution in PBS/BSA  and 
incubated at 37°C for 15 rain. Next, 0.1 ml of EAC was added to the neutrophil suspension and the 
mixture was analyzed for inhibition rosette formation by comparison to a simultaneous control in 
which PBS/BSA was substituted for the C-fragment dilution. 
Results 
Separation  of Myeloid Cells of Different Maturation  Stage  by Density Gra- 
dient Centrifugation.  Ficoll-Hypaque gradients containing seven density steps 
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TABLE  I 
Detection of EAC Rosettes and Ia Antigens with Normal Neutrophils  Separated  by 
Density Gradient Centrifugation 
I  Propor-  Myeloid cell markers*  Wright-Giemsa morphology 
tion of 
Cell source  Density layer  total  Rosette formation with  I Ia Fluor.  Blast.  Pro.  rata. 
Myel.-  Band  PMN  Lyre.  Mon. 
cells  ~ACI4blEAC I_3blEAC l_3d 
g/ml  •  %  % 
Normal  1.07  26  ND  ND  ND$  0  2  5  4  75  13 
blood  (6~  1.08  11  ND  ND  ND  0  0  5  7  68  17 
1.09  6  81  51  0  0  0  5  71  19  2 
1.105  30  86  18  0  0  0  0  10  87  2  0 
1.12  20  93  5  0  0  0  6  93  0  0 
>1.12  7  76  23§  0  0  0  5  50  6  2 
Unseparated  100  86  17  0  0  0  0  6  66  22  2 
Normal  1.0511  4  2  4  44  10  6  i  7  0  0  25  2 
marrow  1.0~l  17  9  17  31  23  7  i  11  1  0  36  4 
(3)  1.07/,  10  17  20  5  1  1  57  8  6  13  3 
1.08  15  32  21  3  0  1140  33  11  15  1 
1.09  1956  25  1  00125552821 
1.105  26  77  41  0  0  0  '  8  36  50  1  0 
1.12  5  54  9  0  2  0  I  3  15  67  2  0 
>1.1211  4  36  17}  1  2  0  3  5  21  5  1 
Unseparate~l  100  43  25  2  1  1  14  16  16  14  1 
Ia fluor, Ia antigen.specific fluorescence; blast.,  myeloblast; pro., promyelocyte; myel.-mta., myelocyte or metamyelocyte; band, 
band form; PMN, polymorphonuclear  neutrophil;  lyre., lymphocyte; men., monocyte. 
• Only myeloid cells enumerated, and thus the proportions given are for the myeioid series only and not for the entire cell fraction. 
$ ND,  not  done  because  myeloid  cello  were  outnumbered  by  monocytes,  and  these  two  cell  types  could  not  be  accurately 
distinguished by phsse-contrast microscopy. 
§ The >l.12-g/ml fractions contained 23-37%  eoeinophils,  most of which formed rosettes with EAC1-3d (19). 
Ir In the 1.05-,  1.06-,  and 1.07-g/ml fractions of nsrmal bone marrow, EAC rcoettce were enumerated from Wright-Giemsa stained 
rosette  smears and  only  cells  of the  myeloid  series were  included.  Nucleated  erythroid  precursors  made  up  a  significant 
proportion of the 1.05,  1.06,  >1.12,  and unseparated  cell fractions (50, 8, 40, and 37%, respectively). 
with  different densities.  The  majority of neutrophils in  normal  blood  were 
characterized by a bouyant density between 1.09 and 1.12 g/ml (Table I).  The 
pellet fraction (>1.12) contained <10% of  the total neutrophils, and the majority 
of eosinophils and erythrocytes. The neutrophil recovery from the gradients was 
75-85% and the purity of neutrophilic cells in the 1.105- and 1.12-g/ml fractions 
was 95-99%,  with 1-5% contamination with lymphocytes and eosinophils. Cell 
fractions obtained at a  density of 1.07-1.08g/ml contained 5-10%  metamyelo- 
cytes  and  band  forms,  1-3%  basophils,  the  majority  of lymphocytes  and 
monocytes, but few  polymorphonuclear cells.  These fractions resembled the 
mononuclear cell fractions obtained by conventional Ficoll-Hypaque centrifu- 
gation according to Beyum (13). 
Myeloid cells from normal bone marrow sedimented according to the degree 
of maturation, so that myeloblasts and promyelocytes were concentrated in low 
density fractions,  whereas polymorphonuclear neutrophils were restricted to 
high density fractions (Table I).  Cell density increased with maturation such 
that myeloblasts were isolated at 1.06-1.07 g/ml, metamyelocytes at 1.07-1.08 g/ 
ml, band forms at 1.08-1.105 g]ml, and polymorphonuclear cells at 1.09-1.12  g/ 
ml. The vast majority of lymphocytes and nucleated erythroid cells in the 1.05- 
1.06-g/ml fractions were small mononuclear cells that were easily distinguished 
from larger myeloblasts and promyelocytes in phase-contrast microscopy. 
Blood from patients with stable-phase CML contained 0.5-3.0  x  l0  s neutro- 734  SURFACE  MARKERS  OF  NEUTROPHIL  MATURATION 
TABLE II 
Separation of Blood Leukocytes from Patients with Myelogenous Leukemia by Density 
Gradient Centrifugation 
Blood source  Density  Proportion of  total 
layer  cells 
Wright-Giemsa  morphology* 
Blast.  Pro.  Myel.  Mta.  Band  PMN  Lym.  Men. 
g/ml  %  % 
Patient  with  1.05  0.1  23  41  15  3  2  1  2  13 
CML  1.06  0.2  4  21  39  13  8  2  6  7 
1.07  25.0  0  2  30  58  8  1  1  0 
1.08  11.1  O  0  14  59  18  5  1  3 
L09  16.3  0  0  3  10  33  54  0  0 
1.105  45.3  0  0  0  7  12  78  1  0 
1.12  1.8  0  0  0  2  I0  88  0  0 
Unseparated  100  0  0  3  15  13  69  0  0 
Patient with  1.05  11.4  84  0  0  2  1  0  0  8 
AML  1.06  10.5  68  14  6  2  4  2  2  3 
1.07  31.4  47  12  5  10  7  5  4  I0 
>1.07,  46.7  37  10  15  23  10  4  10  2 
Unseparated  10O  49  10  10  8  6  5  6  5 
Abbreviations are explained in the legand to Table I. 
* 300 cells  counted in each density layer; thus 0% implies <0.3%. 
* No cells  in layers 1.08, 1.09,  1.105, or 1.12 g/ml. The >1.07 fraction was the cell  pellet  in a tube containing 1.05-,  1.06-,  and 1.07- 
g/ml layers. See abbreviations in Table I. 
phils/ml, the majority of which were polymorphonuclear (Table II).  Because 
only 0.1-1.5% of blood cells from these patients were myeloblasts and promye- 
locytes,  density separation  proved to  be  of considerable value  in  obtaining 
sufficient numbers of immature cells for surface marker analysis. Low density 
fractions contained 4-77% myeloblasts and promyelocytes, an enrichment of 50- 
to 300-fold compared with the unseparated leukocytes. 
Blood from patients with acute myelogenous leukemia (AML) contained 50- 
80% myeloblasts and promyelocytes. Over 50% of these cells had a density < 1.07 
g/ml (Table H), however as many as 10% of the myeloblasts from AML patients 
often exhibited a more heterogeneous density distribution than those isolated 
from either normal bone marrow or patients with CML (regardless of whether 
they were in stable phase or blast phase). 
EAC Rosette Formation  with Normal Neutrophils.  An average of 17% of 
normal blood  neutrophils formed rosettes with EAC1-3d.  This proportion of 
neutrophil rosettes with these immune adherence (human E rosette)-negative 
EAC1-3d was uneffected by retreatment of the EAC1-3d with C3b inactivator 
(and fllH) two times. However, when normal blood neutrophils were separated 
by density gradient centrifugation, the small proportion of neutrophils forming 
EAC1-3d rosettes was concentrated to 51% in the 1.09-g/ml  fraction, and the 
highest density 1.12-g/ml fraction formed only 6% EAC1-3d rosettes (Table I). 
Thus, the neutrophils forming EAC1-3d rosettes were of lower density than the 
majority of neutrophils,  and the proportion of neutrophils forming EAC1-3d 
rosettes decreased with increasing cell density. The majority of neutrophils had 
a density _  1.105 g/ml and did not form EAC1-3d rosettes. By contrast, >90% of 
normal blood neutrophils formed rosettes with either EAC14b or EAC1-3b, and 
EAC14b and EAC1-3b rosette formation increased slightly with increasing cell 
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TABLE  HI 
Competitive Inhibition of C Receptors on High-Density Polymorphonuclear Neutrophils 
by Fluid-Phase Complement Fragments 
Source and description of  EAC rosette  Concentration 
neutrophils  type  of C fragment 
Inhibition of rosette formation 
by fluid phase 
C4b  C3b  C3c  C3d 
~g/ml  % 
Normal blood  EAC14b  400  74  98 
1.12 g/ml density layer  200  60  72 
98% polymorphonuclear  100  31  46 
Rosette formation  50  12  20 
EAC14b =  95% 
EAC1-3b =  97% 
EAC1-3d =  2% 
EAC1-3b 
57  ND* 
35  -4 
22  -2 
8  1 
400  61  71  56  ND 
200  35  53  29  -4 
100  24  32  16  0 
50  7  12  4  3 
* ND, not done. 
Among normal marrow myeloid cells, 25% formed rosettes with EAC1-3d and 
44% formed rosettes with either EAC14b  or EAC1-3b.  Compared with normal 
blood, the 1.09- to 1.12-g/ml density fractions of normal marrow were heteroge- 
neous in neutrophil morphology, containing lower proportions of polymorpho- 
nuclear cells and higher proportions of immature neutrophils. The marrow 1.12- 
g/ml  fraction resembled the  1.12-g/ml  fraction of normal blood  in  that  the 
proportion of EAC1-3d  rosettes was  considerably less  than in  the  1.09- and 
1.105-g/ml fractions, and the majority of cells in the 1.12-g/ml fraction formed 
rosettes only with EAC14b and EAC1-3b  (Table I). However, the marrow 1.12- 
g/ml fraction represented only 5% of  marrow cells, as compared to 20% of normal 
blood leukocytes. The majority of marrow.myeloid cells were lower density and 
less mature than blood neutrophils and did not form EAC rosettes. 
Specificity and Number of Different Types of Neutrophil C Receptors.  Two 
different neutrophil fractions were examined for competitive inhibition of EAC 
rosette formation by fluid-phase fragments of C4 and C3. One fraction consisted 
of normal  blood  polymorphonuclear neutrophils  isolated  at  1.12 g/ml,  that 
formed a high proportion of rosettes with both EAC14b and EAC1-3b, but very 
few rosettes with EAC1-3d (Table III). The other neutrophil fraction was a 1.08- 
g/ml density fraction, that formed similar proportions of rosettes with all three 
EAC types. This latter fraction was obtained from the blood of a patient with 
CML and consisted of 60% polymorphonuclear neutrophils, 30% band forms, 
and 10% immature myeloid cells (Table IV). This cell preparation was chosen 
because  the  large  number of cells  available  permitted the  assay  of many 
different C-fragment dilutions with each EAC type. Similar results were also 
obtained on a smaller scale when normal marrow ceils of similar density and 
composition were used instead of leukemic cells. 736  SURFACE  MARKERS  OF  NEUTROPHIL  MATURATION 
TABLE  IV 
Competitive Inhibition of C Receptors  on Low-Density Polymorphonuclear  and Band 
Neutrophils by Fluid-Phase C Fragments 
Source and description  of  EAC rosette  Concentration 
neutrophils  type  of  C fragment 
Inhibition of rosette formation 
by fluid phase 
C4b  C3b  C3c  C3d 
ug/ml 
Leukemic blood  EAC14b  400 
1.08 g/ml density layer  200 
30%  bands, 60% polymorphs  100 
Rosette formation  50 
EAC14b  =  62% 
EAC1-3b  =  73% 
EAC1-3d  =  55% 
EAC1-3b 
% 
65  78  26  -6 
44  64  13  -7 
35  55  6  -3 
28  51  8  -2 
400  20  61  24  12 
200  16  34  13  10 
100  10  26  8  -2 
50  5  12  4  0 
EAC1-3d  600  4  ND*  ND  ND 
400  0  45  -  10  85 
300  ND  31  0  57 
100  ND  10  ND  20 
5O  ND  -5  ND  15 
* ND,  not done. 
With normal blood high-density polymorphonuclear neut~phils  (Table  III), 
fluid-phase C4b, C3b, and C3c each produced  dose-dependent inhibiton of both 
EAC14b  and  EAC1-3b  rosette  formation,  whereas  fluid-phase  C3d  had  no 
demonstrable effect. Since the molecular weight of C3d was 14-20% of the other 
fragments, the molar concentrations of C3d employed were five to seven times 
greater  than  for the  other fragments.  Parallel  tests  of lymphocytes  demon- 
strated  that  this  C3d  fragment  preparation  was  fully  active  in  blocking 
lymphocyte  Cl~-dependent  rosettes.  EAC14b  rosettes  were  more  easily  in- 
hibited than were EAC1-3b rosettes, but in both cases the different fragments 
had  the  same  relative  inhibitory  capacity:  C3b  >  C4b  >  C3c.  Thus,  C4b 
inhibited EAC1-3b rosettes and C3c inhibited EAC14b rosettes, indicating that 
neutrophils contain a single CRl-type receptor that is specific for either C4b or 
the C3c region of C3b. 
A  somewhat  different result  was  obtained  with  fractions  containing  less 
mature  neutrophils  (Table  IV).  EAC1-3b  rosette  formation  was  inhibited 
slightly by high concentrations of fluid-phase C3d,  while fluid-phase C4b and 
C3c each produced less than half as much inhibition of EAC1-3b rosettes as did 
fluid-phase C3b.  This suggested that C3b was bound by receptors specific for 
both the C3c and C3d regions. The binding of C3b to C3d region receptors (CI~) 
was confirmed by the observation that fluid-phase C3b, as well as C3d, caused 
significant inhibition of EAC1-3d rosette formation. EAC14b was bound only to 
C3c region receptors (CRy), because EAC14b rosettes were inhibited by fluid- ROSS,  JAROWSKI,  RABELLINO,  AND  WINCHESTER 
TABLE V 
Expression  of CR1, CR2, and la Antigens on Leukemic Myeloid Cells 
737 
Number 
Cell source  of  Density  CR1  CR2 
patients  layer 
Ia Ag 
CML 
High CI~ (>50%) 
Low CI~ (<25%)  9 
AML  5 
g/ml  % 
1.05-1.07  19  47  25 
1.08-1.09  49  66  2 
1.105  84  42  0 
1.12  86  44  0 
1.05-1.07  27  11  19 
1.08-1.09  53  15  1 
1.105  78  26  0 
1.12  64  6  0 
1.05-1.07  32  16  53 
1.08-1.09  47  25  10 
1.105  69  49  2 
1.12  47  40  3 
phase C3c and C3b, but not by C3d, and because fluid-phase C4b did not inhibit 
EAC1-3d rosette formation. These results indicated that immature neutrophils 
contained  CRy- and  Cl~-type receptors similar  to  those  of B  lymphocytes. 
Because of the dual reactivity of C3b with both CR~ and CI~, EAC14b rosette 
formation was used instead of EAC1-3b rosette formation as a specific marker 
of CR,, and EAC1-3d rosette formation was used as a specific marker of CRy. 
Sequential Expression of CR,  and CR2 at Different Stages of Neutrophil 
Maturation.  The observation with blood and marrow that CI~ was expressed 
more  on  low  density  immature  neutrophils  than  on  high  density mature 
neutrophils, suggested that Cl~ was expressed during neutrophil maturation 
before the appearance ofCR,, and thus might be a marker of  relative neutrophil 
immaturity. The support for this was provided by the finding that the low 
density immature neutrophils from 7 out of 16 patients with CML contained 
significantly more CI~- than CR,-bearing cells, whereas the high-density more 
mature neutrophils from these same seven patients contained more CR1- than 
CRy-bearing cells. The neutrophils from these seven CML patients were grouped 
together because they differed from those of other patients and normal marrow 
in that they contained a high proportion of CRy-bearing cells (Table V). In these 
seven CML patients, the excess of CRy-bearing cells were isolated in low density 
fractions along with the relatively less mature cells, whereas in the remaining 
patients and in normal marrow, the proportion of Cl~-bearing cells was less 
than the proportion of CRy-bearing cells in all density fractions. All of these 
neutrophil preparations resembled normal blood neutrophils in that CI~ was 
decreased on mature neutrophils in  1.12-g/ml  fractions as  compared to  the 
relatively less mature neutrophils contained in low and intermediate density 
fractions.  Thus,  high  density mature neutrophils consistently lost  CP~  and 
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TABLE  VI 
Expression of CR ~  and CR2 on Neutrophil Maturation Stages 
Isolated from Normal Bone Marrow 
Wright-Giemsa  CR~  CR2 
morphology 
%  % 
Myeloblast  1  2 
Promyelocyte  2  3 
Myelocyte  3  18 
Metamyelocyte  18  21 
Band form  29  23 
Polymorphonuclear  54  35 
Since the presence of normal marrow CR,- CI~  + immature neutrophils could 
not be inferred from measurement  of  the overall proportions of cells bearing CR1 
and  CR2  in  low  density fractions,  the  C-receptor type  of immature and 
mature neutrophils was separately evaluated by examining fixed smears of 
neutrophil rosettes stained with Wright-Giemsa (Table VI). An average of 18% 
of myelocytes expressed CI~,  but only 3%  of myelocytes expressed CR1. CR1 
appeared on 18% of metamyelocytes bearing CI~,  and then the expression of 
both types of C receptors gradually increased with cell maturation until the low 
density polymorphonuclear stage.  Finally,  high  density polymorphonuclear 
neutrophils primarily expressed only CR, and lacked CI~. 
Independent Expression of Ia Antigens and C Receptors.  Human Ia anti- 
gens were detected by immunofluorescence  on immature myeloid cells isolated 
at densities -  1.06 g/ml from normal bone marrow or leukemic blood (Tables I, 
V). Ia determinants were only detected on myeloid cells that had the appearance 
of myeloblasts and promyelocytes in phase-contrast microscopy, and this was 
supported by parallel examination of preparations after Wright-Giemsa stain- 
ing. In all of the normal marrows and in most cases of leukemia, myeloid cells 
containing C receptors were isolated at higher densities than cells expressing Ia 
antigens. Occasionally, however, cell fractions isolated from leukemic blood at 
intermediate densities contained both Ia antigen-bearing cells and C-receptor- 
bearing cells.  These were studied to determine if Ia determinants and CR, or 
CI~ were expressed on the same cells.  Double-marker studies of 800 Ia-bearing 
cells from three individuals with CML revealed that 97-99% of Ia-bearing cells 
lacked both CR1 and CI~. 
Discussion 
The principal finding of the present study was that Ia antigens and two types 
of C  receptors  (CR1 and  CI~)  were expressed on the membrane surfaces of 
human neutrophils in a distinct sequence during maturation. The two types of 
neutrophil C receptors had a similar specificity to those previously described on 
the surface of B lymphocytes (14). Ia antigens were only detected at the earliest 
stage of maturation before the appearance of either type C receptor. Thus, the 
sequence of appearance of these three surface markers defined four potential 
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Ia -~ CI~ -* CR, CR¢ --* CR, 
Since po]ymorphonuclear  neutrophils are the predominant mye]oid  cell form 
in both normal bone marrow and blood  from  patients with CML, surface  marker 
analysis of immature neutrophils required separation of immature and mature 
granulocytes. Several previous  studies have shown  that immature  myeloid  cells 
had a lower  density than did mature granulocytes (15-18). The density gradient 
technique was  particularly  valuable both for isolating myeloblasts and for 
separating mature neutrophils from eosinophils.  Whereas normal bone marrow 
contained  only  0.1-2.0% myeloblasts,  low density fractions  isolated from  marrow 
contained an average of 23% myelob]asts. Furthermore, low density fractions 
obtained from  the blood  of  patients with CML were  enriched from  50- to 300-fold 
in the proportion of myeloblasts. 
The specificity  and number of neutrophil C receptors was determined in the 
same way as was previously reported with B lymphocytes,  erythrocytes, and 
eosinophils (14, 19). Low and intermediate density neutrophils differed from 
high density neutrophils in that variable proportions of the low density cells 
formed EACI-3d rosettes, whereas high density neutrophils formed rosettes 
with EACI4b  and EACI-3b  but not with EACI-3d. This suggested  that low den- 
sity immature neutrophils might contain only CR~ and high density mature 
neutrophils might lack CR2 and contain only  CR,. For this reason, the C recep- 
tor specificity  of neutrophils was separately analyzed in two different density 
fractions. The first was a I. 12-g/m] fraction containing only  po]ymorphonuclear 
neutrophi]s that formed rosettes with  EACI4b and EACI-3b but not with 
EACI-3d, and the other was a morphologically  less mature 1.08-g/ml fraction 
that formed similar proportions of rosettes with all three types of EAC. The 
finding that EACI-3d rosettes were inhibited by fluid-phase C3d and C3b, but 
not by fluid-phase  C3c or C4b, indicated that low density neutrophils contained 
a C3d receptor that had similar specificity  to the CR~ of B lymphocytes (14). 
Polymorphs that did not form EAC1-3d rosettes,  contained  a  single  CR, 
type of receptor for EACI4b and EACI-3b rosette formation, because complete 
cross-blocking by fluid-phase C4b, C3b, and C3c fragments was observed. Of 
these three fragments, C3b had the highest affinity for CR,, followed  next by 
C4b and then C3c. Low density neutrophils that contained both CR, and CR¢ 
differed slightly in the mechanism of EACI-3b rosette formation from  their 
high density counterparts. Fluid-phase C4b and C3c produced  considerably  less 
inhibition of EACI-3b rosette formation  than did fluid-phase C3b, and fluid- 
phase  C3d  produced slight  inhibition  of EACI-3b rosette  formation. This 
suggested that C3b was partially bound to CR¢, even though most of the C3b 
was bound to CR,. The binding of  C3b to C3d region receptors (CI~) was further 
confirmed by the demonstration of strong inhibition of EAC1-3d rosettes by 
fluid-phase C3b. Thus, neutrophil C receptors had identical specificity  to the 
analogous receptors of B lymphocytes,  eosinophils, and erythrocytes (14, 19). 
CR, was specific  for C4b, C3c, or the C3c region of  C3b, and CI~ was specific  for 
C3d fragments or the C3d region of C3b. 
In the present study only 17% of normal blood neutrophils were found  to 
contain CI~, and these were concentrated at the 1.09-g/m] density interface, 
whereas the majority of blood neutrophi]s had a higher density and contained 740  SURFACE  MARKERS  OF  NEUTROPHIL  MATURATION 
TABLE  VII 
Correlation of Surface Markers with Maturation Stage and Cell 
Density 
Myeloblast  , Promyelocyte  ~ Myelocyte  ~ Metamyelocyte 
1.05-1.06  g/ml  1.06 g/ml  1.07 g/ml 
Ia+CR,-CR2  -  Ia-CR,-CR2  +  Ia-CR,+CR2  + 
band form  ,  polymorph ....  ,  polymorph 
1.08 g/ml  1.09-1.105 g/m]  1.12 g/ml 
Ia-CR,+CR2  +  Ia-CR,+CR2  +  Ia-CR,+CR¢  - 
only CR,.  Previously, neutrophils were believed to bear only CR,  and to lack 
CP~. Gigli and Nelson (2) had demonstrated inhibition ofEAC1-3b phagocytosis 
by C3b inactivator, and more recent studies overlooked neutrophil Cl~ because 
low density polymorphs were excluded by the isolation procedure, or alterna- 
tively, a low proportion of  EAC1-3d rosettes were ascribed to residual uncleaved 
C3b or C4b on the EACI-3d (3, 4). 
Parallel assays of density gradient fractions for surface markers and Wright- 
Giemsa stain morphology demonstrated a  distinct sequence of appearance of 
surface markers during neutrophil maturation, la antigens were present on 
myeloblasts and rare promyelocytes, and double-marker assays demonstrated 
that Ia determinants were lost before the first appearance of CI~ on 18%  of 
myelocytes. The  proportion  of myeloid cells expressing Cl~  increased with 
maturation until the low density polymorphonuclear stage and then decreased 
as polymorph density increased from 1.09 to i. 12 g/ml. CR, appeared first along 
with CR~  on  18%  of metamyelocytes and was maximally expressed on CRy- 
negative,  high  density  polymorphonuclear neutrophils.  The  correlation  of 
surface markers, maturation stage,  and cell density is summariT~l in Table 
VII. 
It  is  important  to  note  that  the  appearance  or  disappearance of surface 
markers was not abrupt at the individual maturation stages defined by Wright- 
Giemsa morphology. Also, although there was some variation in the relative 
time-course of marker expression among different cell preparations, the overall 
sequence of marker expression was apparently always the same. For example, 
Ia  determinants were  usually  not  detectable  on  the  cell  surface after the 
promyelocyte  stage, however, in some few patients with CML, rare myelocytes 
and  metamyelocytes contained Ia  determinants, while  in  some other CML 
patients, Ia determinants were only detectable on 20-40% of myeloblasts and 
were absent from the majority of myeloblasts and more mature myeloid  cells. In 
particular, C receptor expression was not strictly correlated with morphologic 
maturation state. The proportion of normal marrow cell bearing CI~ increased 
from 18% at the myelocyte stage to 35% at the polymorph stage, and thus it is 
unclear whether or not all neutrophils pass through a  CR2-positive  stage at 
some time during their development. CR2 expression may be a characteristic 
feature of a distinct subset of neutrophils, for example, those that make up the 
marginating pool of noncirculating neutrophils. Alternatively, CR2 expression 
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release of cells into the periphery, so that the kinetics of release prevent the 
accumulation of Cl~¢-bearing cells in the marrow. This latter mechanism may 
also explain the finding that only half of marrow high density morphologically 
mature  neutrophils  contain  CR,,  whereas  nearly  all  of peripheral  blood 
neutrophils bear CR,. 
Thus, although there was a defined order of appearance of surface markers 
during maturation, the sequence was sometimes shifted slightly either to the 
right or to the left relative to the sequence of morphological maturation, and all 
three surface markers examined were sometimes undetectable on a proportion 
of the myeloid cells at any one stage of maturation. Studies of cultured murine 
leukocytes have demonstrated that the expression of C receptors can be induced 
on  myeloblasts with prednisolone and  actinomycin D  (20). Taken together, 
these findings suggest that the regulation of membrane differentiation may be 
independent from the events of nuclear and cytoplasmic maturation defined by 
standard morphologic criteria. 
Since CR1 and CI~ are also present on B lymphocytes and macrophages, and 
these  cell  types  and  neutrophils  are  believed to  originate from  a  common 
marrow stem cell, it is possible that these other cell types may have the same 
sequence of C-receptor appearance during maturation as do neutrophils. For 
example,  B  lymphocytes from normal blood,  considered to  be  at  a  stage of 
relative maturity, are either CR1 + CI~ + or CR1 + CR2-. On the other hand, in 
tonsils, leukemic blood,  and normal bone marrow,  2 each believed to contain a 
proportion of more immature B cells, a  significant proportion of lymphocytes 
are CRc CI~  + (3, 14). There is also similarity in the terminal phase of murine 
macrophage differentiation into activated cells, CR1 + CI~ + --* CR1 + CRy-  (5). 
Thus, with granulocytes, monocytes, and B lymphocytes, there may be a similar 
sequence of C-receptor appearance during cell differentiation: CR2 --* CR~ CI~ 
--* CR,. The same sequence of C receptor appearance was also found in parallel 
studies of murine neutrophil maturation (5,  21, 22). The only difference in C- 
receptor expression  between  the  two  species  was  in  the  incidence of CR~ 
expression on blood polymorphs. The vast majority of mouse blood polymorphs 
contained both  CR1  and  CI~,  while  by contrast,  only  17%  of human blood 
polymorphs contained both types of C receptors (5). 
The functional significance of a CR~ + CI~- profile on fully mature neutrophils 
and activated macrophages has been difficult to explain in relation to a plasma 
C3b inactivator that renders EAC14b and EAC1-3b complexes unreactive with 
CRy-bearing cells.  Immune complexes in  plasma  fix  C4b  and  C3b  that  are 
rapidly cleaved by  the  plasma  C3b  inactivator into  the  respective c  and  d 
fragments (11, 23). The C4b cleavage products, C4c, rand C4d, are beth believed 
to be unreactive with C receptors (24), while the complex-bound C3b cleavage 
product, C3d, only has activity with CI~. In vivo however, C4b sites on immune 
complexes may be partially protected from C3b inactivator cleavage by forma- 
tion either of a  short-lived complex with  C2  (11) or with the low molecular 
weight C4b-binding protein (25). This may help preserve C4b sites long enough 
to allow attachment of immune complexes to CR,-bearing phagocytes. There is 
similar complexity in the in vivo reactions involving immune complex-bound 
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C3b. It is well known that when the immune complexes are sheep erythrocytes 
(EAC), the cell-bound C3b cleavage product, the C3d fragment, has little or no 
opsonic activity (2, 26, 27). However, under normal circumstances in vivo, C3- 
coated bacteria and yeast are the more usual fare of  phagocytes, and erythrocyte 
target  cells  are  more  likely  to  be  handled  instead  by  lysis  with  natural 
antibodies and complement. Many strains of bacteria and yeast spontaneously 
trigger the alternative pathway of C activaton and as a  result become coated 
with C3b that is subsequently cleaved by C3b inactivator. However, in contrast 
to sheep cell membranes, Stossel et al. (26) have shown that bacterial cell wall- 
derived lipopolysaccharide-coated paraffin oil particles  retain  an opsonically 
active form of C3 despite prolonged incubation with whole serum. FurthermOre, 
Fearon and Austen (28) have demonstrated that yeast cell wall-derived zymosan 
surfaces differ from sheep erythrocyte membranes in that alternative pathway- 
derived C3b is bound in such a way that it is relatively resistent to cleavage by 
C3b inactivator. Thus, with both bacteria and yeast, C3b may be an effective 
CR,  reactive  opsonin despite the  presence  of C3b  inactivator,  and  mature 
phagocytes may only need to contain CR, type C receptors for effective clearance 
of these microbes. 
Summary 
Ia antigens and two different types of complement (C) receptors appeared on 
membrane surfaces in  a  distinct sequence during the maturation of human 
neutrophils.  Taking  advantage  of the  finding that  neutrophil  cell  density 
increased with maturation, density gradient centrifugation was used to separate 
neutrophils  into  fractions  that  were  greatly  enriched  in  cells  representing 
individual stages of differentiation. Myeloblasts, the earliest cells recognized in 
the  myeloid series  of both  normal  and  myelogenous leukemic individuals, 
expressed Ia determinants, whereas Ia determinants were absent or diminished 
on the majority of promyelocytes and completely undetectable on more mature 
granulocytes. Double marker studies demonstrated that Ia determinants were 
lost from the membrane of developing myeloid cells before the appearance of 
any type of C  receptor.  In the next phase of maturation defined by surface 
markers, neutrophils acquired a  Cl~-type C receptor (C3d receptor) that was 
similar  in  specificity  to  CR2  of B  lymphocytes.  This  stage  of maturation 
approximately corresponded to the myelocyte-metamyelocyte stage defined by 
standard morphologic criteria, and preceded the third stage of surface marker 
maturation when developing neutrophils began to express CR,-type C receptors 
(immune adherence, C4b-C3b receptors) in addition to CI~. In the final stage of 
surface marker-defined maturation, CR¢ was lost from high density polymor- 
phonuclear  neutrophils  and  CR,  was  maximally  expressed.  Normal  blood 
polymorphonuclear neutrophils contained only  17%  of Cl~-bearing cells and 
these were shown to be of lower density than the majority of neutrophils that 
expressed only CR,.  There was some variation in the correlation of surface 
marker expression and maturation stage defined by morphologic criteria, but in 
all cases the sequence of marker appearance was the same: 
la --+ CR¢ --* CR, CR2 -+ CR, ROSS,  JAROWSKI,  RABELLINO,  AND  WINCHESTER  743 
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